Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet

Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease

(2011) V. W.-S. Wong et al.   GUT

3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: A therapeutic controversy

(2011) Maria Tzefos et al.   Journal of Clinical Lipidology

The many facets of PPARγ: novel insights for the skeleton

(2010) Masanobu Kawai et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Beneficial effects of exercise training (treadmill) on insulin resistance and nonalcoholic fatty liver disease in high-fat fed C57BL/6 mice

(2010) C.M.M. Marques et al.   BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet

(2010) Vanessa Souza-Mello et al.   CLINICAL SCIENCE

Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: A 24-week, randomized, open-label, prospective study

(2010) Christos V. Rizos et al.   CLINICAL THERAPEUTICS

Genetic control ofde novolipogenesis: role in diet-induced obesity

(2010) Maggie S. Strable et al.   CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY

A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet

(2010) Julio C. Fraulob et al.   JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION

The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver disease

(2010) Yuichiro Eguchi et al.   JOURNAL OF GASTROENTEROLOGY

Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease

(2010) Giovanni Targher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of diet and exercise on metabolic disturbances in high-fat diet-fed mice

(2009) Victoria J. Vieira et al.   CYTOKINE

SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats

(2009) Manuela Aragno et al.   FREE RADICAL BIOLOGY AND MEDICINE

Cardiac safety profile of rosiglitazone

(2009) Edoardo Mannucci et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Endoplasmic reticulum stress involved in the course of lipogenesis in fatty acids-induced hepatic steatosis

(2009) Jiang Liu et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Hepatic lipid metabolism and non-alcoholic fatty liver disease

(2009) P. Tessari et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Effect of rosuvastatin on insulin sensitivity in an animal model of insulin resistance: Evidence for statin-induced hepatic insulin sensitization

(2008) Mark Naples et al.   ATHEROSCLEROSIS

Palmitate Impairs and Eicosapentaenoate Restores Insulin Secretion Through Regulation of SREBP-1c in Pancreatic Islets

(2008) T. Kato et al.   DIABETES

SREBPs: physiology and pathophysiology of the SREBP family

(2008) Hitoshi Shimano   FEBS Journal

Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial

(2008) Vlad Ratziu et al.   GASTROENTEROLOGY

Rosiglitazone: Possible complications and treatment of non-alcoholic steatohepatitis (NASH)

(2007) Jens H. Henriksen et al.   JOURNAL OF HEPATOLOGY

Statin modulates insulin signaling and insulin resistance in liver and muscle of rats fed a high-fat diet

(2007) Cristina Alba Lalli et al.   METABOLISM-CLINICAL AND EXPERIMENTAL